Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

BIAF stock hub

bioAffinity Technologies, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIAFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BIAF

In the news

Latest news · BIAF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-622.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-184.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIAF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001712762
Company name	bioAffinity Technologies, Inc.
Country	United States
Country code	US
Cusip	09076W307
Employees	57
Employees Change	-18%
Employees Change Percent	-24
Enterprise value	$7.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2022-09-01
Isin	US09076W3079
Last refreshed	2026-05-10
Market cap	$9.1M
Market cap category	Nano-Cap
Price	$2.03
Price currency	USD
Rev Per Employee	99,296.3x
Sector	Healthcare
Sic	8731
Symbol	BIAF
Website	https://bioaffinitytech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-174.06%
EV Sales Forward	1.43x
EV/Sales	1.31x
P/B ratio	2.49x
P/S ratio	1.61x
PS Forward	1.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-204.29%
EBITDA Margin	-194.17%
Gross margin	33.08%
Gross Profit	$1.9M
Gross Profit Growth	-38.23%
Gross Profit Growth Q	-12.94%
Gross Profit Growth3 Y	612.79%
Net Income	$-15.9M
Net Income Growth Years	0%
Pretax Margin	-279.95%
Profit Margin	-280.57%
Profit Per Employee	$-278,596
ROA	-107.1
Roa5y	-81.94
ROCE	-242.9
ROE	-622.6
ROIC	-184.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-68.23%
Cagr3y	-67.81%
EPS Growth Quarters	7
EPS Growth Years	5
Revenue Growth	-35.75x
Revenue Growth Q	-27.09x
Revenue Growth Years	0x
Revenue Growth3 Y	896.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.84
Assets	$7.9M
Cash	$3.1M
Current Assets	$4.3M
Current Liabilities	$3.2M
Debt	$1.4M
Debt Equity	$0.38
Equity	$3.7M
Interest Coverage	-265.1
Liabilities	$4.3M
Long Term Assets	$3.6M
Long Term Liabilities	$1.1M
Net Cash	$1.7M
Net Cash By Market Cap	$18.81
Net Debt Equity	$-0.47
Tangible Book Value	$1.6M
Tangible Book Value Per Share	$0.35
WACC	-1.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.36
Inventory Turnover	64.93
Net Working Capital	$-1.7M
Quick ratio	1.19
Working Capital	$1.2M
Working Capital Turnover	$-28.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-492.83%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-68.2%
200-day SMA	3.3
3Y total return	-96.67%
50-day SMA	2.61
50-day SMA vs 200-day SMA	50under200
All Time High	466.5
All Time High Change	-99.56%
All Time High Date	2022-09-01
All Time Low	0.69
All Time Low Change	192.93%
All Time Low Date	2026-02-05
ATR	0.35
Beta	-1.19
Beta1y	-2.78
Beta2y	-3.6
Ch YTD	72.03
High	2.12
High52	15
High52 Date	2025-05-28
High52ch	-86.46%
Low	2.01
Low52	0.69
Low52 Date	2026-02-05
Low52ch	192.93%
Ma50ch	-22.07%
Premarket Change Percent	-2.58
Premarket Price	$2.07
Premarket Volume	15,762
Price vs 200-day SMA	-38.39%
RSI	39.99
RSI Monthly	34.96
RSI Weekly	42.77
Sharpe ratio	0.29x
Sortino ratio	0.62
Total Return	-492.83%
Tr YTD	72.03
Tr1m	-50.37%
Tr1w	-7.31%
Tr3m	138.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-2.4
Earnings Revenue Estimate	1,483,000x
Earnings Revenue Estimate Growth	-20.01x
Operating Income	$-11.6M
Operating margin	-204.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,266,320%
Float Percent	94.93%
Shares Insiders	5.07%
Shares Institutions	4.89%
Shares Out	4,494,304
Shares Qo Q	0.54%
Shares Yo Y	492.83%
Short Float	12.09%
Short Ratio	0.04
Short Shares	11.48

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	410,596x
Bv Per Share	0.81
Ch1m	-50.37
Ch1w	-7.31
Ch1y	-68.2
Ch3m	138.5
Ch3y	-96.67
Ch6m	-1.46
Change	-4.25%
Change From Open	-4.25
Close	2.12
Days Gap	0
Depreciation Amortization	572,700
Dollar Volume	375,903.2
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-11.6M
EBITDA	$-11M
EPS	$-5.89
F Score	2
Fiscal Year End	December
Founded	2,014
Goodwill	1,404,486
Income Tax	$35,347
Ipr	-66.88
Iprfo	-99.19
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2025-09-19
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	1.98
Ma150ch	2.78%
Ma20	2.46
Ma20ch	-17.45%
Next Earnings Date	2026-08-13
Open	2.12
Optionable	No
Position In Range	18.18
Post Close	2.03
Postmarket Change Percent	-4.43
Postmarket Price	$1.94
Ppne	1,484,327
Pre Close	2.12
Price Date	2026-05-08
Ptbv Ratio	5.87
Relative Volume	0.45x
Revenue	5,659,889x
Tax By Revenue	0.62x
Tr6m	-1.46%
Us State	Texas
Volume	185,174

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BIAF pay a dividend?

Capital-return profile for this ticker.

Performance

BIAF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIAF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.9%

Float: +94.9% of shares outstanding

Insider ownership

+5.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BIAF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.0

Neutral momentum band

Price vs 200-day MA

-38.4%

50/200-day relationship not available

Beta (5Y)

-1.19

Less volatile than the market

Sharpe ratio

0.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIAF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BIAF stock rating?

bioAffinity Technologies, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BIAF analysis?

The full report lives at /stocks/BIAF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BIAF?

The latest report frames BIAF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BIAF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.